Обезболивающие свойства конденсированного производного бензимидазола
жүктеу/скачать 1.96 Mb.
|
| . - 2002. - 946. – P.262–271.
Szmuszkovicz, J. U-50,488 and the kappa receptor / J. Szmuszkovicz // Part II: 1991-1998. Progress in Drug Research. - 1999. – 53. – P.1-51. Tabatabai, S.M. Phytotherapy of Opioid Dependence and Withdrawal Syndrome: A Review / S.M. Tabatabai, S. Dashti, F. Doosti, H. Hosseinzadeh // Phytother Res. – 2013. – 28(5). – P. 1-20. Tadagaki, K. History and biological significance of GPCR heteromerization in the neuroendocrine system / K. Tadagaki, R. Jockers, M. Kamal // Neuroendocrinology. – 2012. - 95(3). – P. 223-231. Tao, Y.M. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential / Y.M. Tao, Q.L. Li, C.F. Zhang // Eur. J. Pharmacol. - 2008. – 584 № 2-3. – P.306–311. Tempel, A. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography / A. Tempel, R.S. Zukin // Proc. Natl. Acad. Sci. USA. – 1987. – 84. – P.4308–4312. Thomas, J.B. Identification of (3r)-7-hydroxy-n-((1s)-1-[[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist / J.B. Thomas, R.N. Atkinson, N.A. Vinson [et al.] // J. Med. Chem. – 2003. – 46. – P.3127– 3137. Thomas, J.B. Identification of the first trans-(3r,4r)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity / J.B. Thomas, R.N. Atkinson, R.B. Rothman [et al.] // J. Med. Chem. – 2001. – 44. – P.2687– 2690. Thompson, A.C. Kappa opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine / A.C. Thompson, A. Zapata, J.B. Justice [et al.] // J. Neurosci. - 2000. – 20. -P.9333-9340. Thomson Reuters Integrity: Официальный сайт поисковой системы «Thomson Reuters Integrity» [Электронный ресурс]. URL: http://integrity.thomson-pharma.com (дата обращения 22.04.2011). Togashi, Y. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820 / Y. Togashi, H. Umeuchi, K. Okano [et al.] // Eur. J. Pharmacol. – 2002. – 435. – P.259–264. Trescot, A. M. Opioid pharmacology / A.M. Trescot, S. Datta, M. Lee, H. Hansen // Pain Physician. - 2008. - 11. - P.133-153. Vanderah, T.W. Delta and kappa opioid receptors as suitable drug targets for pain / T.W. Vanderah // Clin. J. Pain. - 2010. - 26(10). - P. 10-15. Vivian, J.A. Opioid receptor effects of butorphanol in rhesus monkeys / J.A. Vivian, M.B. Deyoung, T.L. Sumpter [et al.] // J. Pharmacol. Exp. Ther. – 1999. – 290. – P.259–265. Vonvoigtlander, P.F. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist / P.F. Vonvoigtlander, R.A. Lahti, J.H. Ludens // J. Pharmacol. Exp. Ther. – 1983. - 224(1). - P. 7-12. Vukojević, V. Opioid Receptors: Cellular and Molecular Mechanisms Underlying Opioid Receptor Function / V. Vukojević, Y. Ming, L. Terenius // Encyclopedia of Signaling Molecules. – 2012. – 1. – P. 1304-1312. Wadenberg, M.L. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist / M.L. Wadenberg // CNS Dr. Rev. - 2003. – 9(2). – P.187-201. Waldhoer, M. A heterodimer-selective agonist shows in vivo relevance of G-protein-coupled receptor dimers / M. Waldhoer, J. Fong, R.M. Jones [et al.] // Proc. Natl. Acad. Sci. USA – 2005. – 102(25). – P.9050–9055. Wall, P.M. Concurrent modulation of anxiety and memory / P.M. Wall, C. Messier // Behav. Brain Res. - 2000. – 109(2). – P.229–241. Wall, P.M. U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice / P.M. Wall, C. Messier // Brain Res. - 2000. – 856(1-2). – P.259–280. Walsh, S.L. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphine in humans / S.L. Walsh, E.C. Strain, M.E. Abreu, G.E. Bigelow // Psychopharmacol. – 2001. – 157. – P.151–162. Wang, D. Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer / D. Wang, X. Sun, L.M. Bohn, W. Sadee // Mol. Pharmacol. - 2005. – 67(6). – P.2173–2184. Wang, Y. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo / Y. Wang, K. Tang, S. Inan [et al.] // J. Pharmacol. Exp. Ther. – 2005. – 312. – P.220–230. Wang, Y.H. The role of kappa-opioid receptor activation in mediating antinociception and addiction / Y.H. Wang, J.F. Sun, Y.M. Tao [et al.] // Acta. Pharmacol. Sin. – 2010. - 31. № 9. – P.1065-1070. Wannemachera, K.M. Purification and mass spectrometric analysis of the κ opioid receptor / K.M.Wannemachera, A. Terskiy, S. Bian [et al.] //Brain Res. – 2008. - 1230. – P.3–26. Wilson, J.L. The importance of the hypothalamo-hypophyseal-adrenal axis to the anti-inflammatory actions of the kappa-opioid agonist PNU-50, 488H in rats with adjuvant arthritis / J.L. Wilson, J.J. Carmody, J.S. Walker // J. Pharmacol. Exp. Ther. - 2000. – 294. - P.1131-1136. Xie, G.X. Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor / G.X. Xie, F. Meng F, A. Mansour [et al.] // PNAS. - 1994. – 91. – P.3779–3783. Xie, Z. Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells / Z. Xie, R.G. Bhushan, D.J. Daniels, P.S. Portoghese // Mol. Pharmacol. - 2005. – 68(4). – P.1079–1086. Yadav, G. Fast dissolving tablets recent advantages: a review / G. Yadav, A. Kapoor, S. Bhargava // IJPSR, - 2012. - 3(3). – P.728 -736. Yamaotsu, N. 3D-pharmacophore identification for kappa-opioid agonists using ligand-based drug-design techniques / N. Yamaotsu, S. Hirono // Top. Curr. Chem. – 2011. – 299. – P.277-307. Yasuda, K. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain / K. Yasuda, K. Raynor, H. Kong [et al.] // Proc. Natl. Acad. Sci. USA. – 1993. - 90. – P.6736–6740. Yekkirala, A.S. Opioid receptors in analgesic drug design – the past, present and future / A.S. Yekkirala// J. of Postdoctoral Research. – 2013. - №4. – P. 9-23. York, P. Design of dosage forms / M.E. Aulton, Kevin M.G. Taylor // Aulton's Pharmaceutics: The Design and Manufacture of Medicines. – 2013. – P.7-18. Zhou, L. Development of functionally selective, small molecule agonists at kappa opioid receptors / L. Zhou, K.M. Lovell, K.J. Frankowski [et al.] // J. Biol. Chem. – 2013. - 288(51). – P. 36703-36716. жүктеу/скачать 1.96 Mb. Достарыңызбен бөлісу:
|